NewsStocks Novo Nordisk Sinks on Obesity Drug Study’s Disappointing Results by admin 20/09/2024 20/09/2024 Key Takeaways Novo Nordisk’s U.S.-listed shares lost ground Friday after a Phase 2a trial of … 0 FacebookTwitterPinterestEmail
